TrialJournal of the International AIDS Society2020

Switching protease inhibitors to rilpivirine in HIV-positive individuals with complete viral suppression and without prior HIV drug resistance in a resource-limited setting: a randomized controlled trial.

Kulissara Palanuphap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.